Osteoclasts control endochondral ossification via regulating acetyl-CoA availability

Abstract

Osteoclast is critical in skeletal development and fracture healing, yet the impact and underlying mechanisms of their metabolic state on these processes remain unclear. Here, by using osteoclast-specific small GTPase Rheb1-knockout mice, we reveal that mitochondrial respiration, rather than glycolysis, is essential for cathepsin K (CTSK) production in osteoclasts and is regulated by Rheb1 in a mechanistic target of rapamycin complex 1 (mTORC1)-independent manner. Mechanistically, we find that Rheb1 coordinates with mitochondrial acetyl-CoA generation to fuel CTSK, and acetyl-CoA availability in osteoclasts is the central to elevating CTSK. Importantly, our findings demonstrate that the regulation of CTSK by acetyl-CoA availability is critical and may confer a risk for abnormal endochondral ossification, which may be the main cause of poor fracture healing on alcohol consumption, targeting Rheb1 could successfully against the process. These findings uncover a pivotal role of mitochondria in osteoclasts and provide a potent therapeutic opportunity in bone disorders.

References

[1] Helfrich MH. Osteoclast diseases. Microsc. Res. Tech., 2003, 61: 514-532

[2] Veis DJ, O’Brien CA. Osteoclasts, master sculptors of bone. Annu. Rev. Pathol. Mech. Dis., 2023, 18: 257-281

[3] Lofvall H et al. Osteoclasts degrade bone and cartilage knee joint compartments through different resorption processes. Arthritis Res. Ther., 2018, 20: 67

[4] Chakrabarty RP, Chandel NS. Mitochondria as signaling organelles control mammalian stem cell fate. Cell Stem Cell, 2021, 28: 394-408

[5] Chandel, N. S. Glycolysis. Cold Spring Harbor Perspect. Biol. 13, a040535 (2021).

[6] Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer., 2004, 4: 891-899

[7] Martinez-Reyes I, Chandel NS, Mitochondrial TCA. cycle metabolites control physiology and disease. Nat. Commun., 2020, 11

[8] Fukushima O, Bekker PJ, Gay CV. Characterization of the functional stages of osteoclasts by enzyme histochemistry and electron microscopy. Anat. Rec., 1991, 231: 298-315

[9] Arnett TR, Orriss IR. Metabolic properties of the osteoclast. Bone, 2018, 115: 25-30

[10] Indo Y et al. Metabolic regulation of osteoclast differentiation and function. J. Bone Miner. Res., 2013, 28: 2392-2399

[11] Lemma S et al. Energy metabolism in osteoclast formation and activity. Int. J. Biochem. Cell Biol., 2016, 79: 168-180

[12] Kim JM et al. Osteoclast precursors display dynamic metabolic shifts toward accelerated glucose metabolism at an early stage of RANKL-stimulated osteoclast differentiation. Cell Physiol. Biochem., 2007, 20: 935-946

[13] Salhotra A, Shah HN, Levi B, Longaker MT. Mechanisms of bone development and repair. Nat. Rev. Mol. Cell Biol., 2020, 21: 696-711

[14] Jones SJ, Boyde A, Ali NN. The resorption of biological and non-biological substrates by cultured avian and mammalian osteoclasts. Anat Embryol., 1984, 170: 247-256

[15] Paiva KB, Granjeiro JM. Bone tissue remodeling and development: focus on matrix metalloproteinase functions. Arch. Biochem. Biophys., 2014, 561: 74-87

[16] Vaaraniemi J et al. Intracellular machinery for matrix degradation in bone-resorbing osteoclasts. J. Bone Miner. Res., 2004, 19: 1432-1440

[17] Zhu G et al. Knockout and Double Knockout of Cathepsin K and Mmp9 reveals a novel function of Cathepsin K as a regulator of osteoclast gene expression and bone homeostasis. Int. J. Biol. Sci., 2022, 18: 5522-5538

[18] Zhu L et al. Osteoclast-mediated bone resorption is controlled by a compensatory network of secreted and membrane-tethered metalloproteinases. Sci. Transl. Med., 2020, 12: eaaw6143

[19] Costa AG, Cusano NE, Silva BC, Cremers S, Bilezikian JP. Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis. Nat. Rev. Rheumatol., 2011, 7: 447-456

[20] Kayal RA et al. TNF-alpha mediates diabetes-enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis through FOXO1. J. Bone Miner. Res., 2010, 25: 1604-1615

[21] Li D et al. Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation. Nat. Commun., 2016, 7

[22] Garnero P et al. The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J. Bone Miner. Res., 2003, 18: 859-867

[23] Chubb SA. Measurement of C-terminal telopeptide of type I collagen (CTX) in serum. Clin. Biochem., 2012, 45: 928-935

[24] Shetty S, Kapoor N, Bondu JD, Thomas N, Paul TV. Bone turnover markers: emerging tool in the management of osteoporosis. Indian J. Endocrinol. Metab., 2016, 20: 846-852

[25] Szulc P, Naylor K, Hoyle NR, Eastell R, Leary ET. Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability. Osteoporosis Int., 2017, 28: 2541-2556

[26] Kahn AJ. Delay of development of responses to ethanol in mice: associated delay in another parameter. J. Stud. Alcohol, 1977, 38: 39-46

[27] Randall CL, Taylor J, Walker DW. Ethanol-induced malformations in mice. Alcoholism, 1977, 1: 219-224

[28] Denys A et al. Binge ethanol exposure in mice represses expression of genes involved in osteoblast function and induces expression of genes involved in osteoclast differentiation independently of endogenous catalase. Toxicol. Sci., 2022, 185: 232-245

[29] Iitsuka N, Hie M, Nakanishi A, Tsukamoto I. Ethanol increases osteoclastogenesis associated with the increased expression of RANK, PU.1 and MITF in vitro and in vivo. Int. J. Mol. Med., 2012, 30: 165-172

[30] Wahl EC et al. Chronic ethanol exposure inhibits distraction osteogenesis in a mouse model: role of the TNF signaling axis. Toxicol. Appl. Pharmacol., 2007, 220: 302-310

[31] Pedersen KB et al. Chronic ethanol feeding in mice decreases expression of genes for major structural bone proteins in a Nox4-independent manner. J. Pharmacol. Exp. Ther., 2020, 373: 337-346

[32] Yamagata K et al. rheb, a growth factor- and synaptic activity-regulated gene, encodes a novel Ras-related protein. J. Biol. Chem., 1994, 269: 16333-16339

[33] Garami A et al. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol. Cell., 2003, 11: 1457-1466

[34] Rogala KB et al. Structural basis for the docking of mTORC1 on the lysosomal surface. Science, 2019, 366: 468-475

[35] Kazak L. Balancing energy demand and production by mitochondrial trafficking of RHEB. Dev. Cell., 2021, 56: 721-722

[36] Lee MN et al. Glycolytic flux signals to mTOR through glyceraldehyde-3-phosphate dehydrogenase-mediated regulation of Rheb. Mol. Cell. Biol., 2009, 29: 3991-4001

[37] Bielajew BJ, Hu JC, Athanasiou KA. Collagen: quantification, biomechanics, and role of minor subtypes in cartilage. Nat. Rev. Mater., 2020, 5: 730-747

[38] Halleen JM, Tiitinen SL, Ylipahkala H, Fagerlund KM, Vaananen HK. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption. Clin. Lab., 2006, 52: 499-509

[39] Wucherpfennig AL, Li YP, Stetler-Stevenson WG, Rosenberg AE, Stashenko P. Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts. J. Bone Miner. Res., 1994, 9: 549-556

[40] Rieman DJ et al. Biosynthesis and processing of cathepsin K in cultured human osteoclasts. Bone, 2001, 28: 282-289

[41] Fonovic M, Turk B. Cysteine cathepsins and extracellular matrix degradation. Biochim. Biophys. Acta, 2014, 1840: 2560-2570

[42] van Meel E et al. Disruption of the Man-6-P targeting pathway in mice impairs osteoclast secretory lysosome biogenesis. Traffic, 2011, 12: 912-924

[43] Ratto E et al. Direct control of lysosomal catabolic activity by mTORC1 through regulation of V-ATPase assembly. Nat. Commun., 2022, 13

[44] Huynh H, Wan Y. mTORC1 impedes osteoclast differentiation via calcineurin and NFATc1. Commun. Biol., 2018, 1: 29

[45] Zhang Y et al. mTORC1 inhibits NF-kappaB/NFATc1 signaling and prevents osteoclast precursor differentiation, in vitro and in mice. J. Bone Miner. Res., 2017, 32: 1829-1840

[46] Fenton TR, Gout IT. Functions and regulation of the 70 kD ribosomal S6 kinases. Int. J. Biochem. Cell Biol., 2011, 43: 47-59

[47] Xu S et al. Rictor Is a novel regulator of TRAF6/TRAF3 in osteoclasts. J. Bone Miner. Res., 2021, 36: 2053-2064

[48] Melser S et al. Rheb regulates mitophagy induced by mitochondrial energetic status. Cell Metab., 2013, 17: 719-730

[49] Yang W et al. Rheb mediates neuronal-activity-induced mitochondrial energetics through mTORC1-independent PDH activation. Dev. Cell., 2021, 56: 811-825

[50] Ma D, Bai X, Guo S, Jiang Y. The switch I region of Rheb is critical for its interaction with FKBP38. J. Biol. Chem., 2008, 283: 25963-25970

[51] Szwed A, Kim E, Jacinto E. Regulation and metabolic functions of mTORC1 and mTORC2. Physiol. Rev., 2021, 101: 1371-1426

[52] Fan H et al. Critical role of mTOR in regulating aerobic glycolysis in carcinogenesis (Review). Int. J. Oncol., 2021, 58: 9-19

[53] Mackie EJ, Ahmed YA, Tatarczuch L, Chen KS, Mirams M. Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int. J. Biochem. Cell Biol., 2008, 40: 46-62

[54] Kafienah W, Bromme D, Buttle DJ, Croucher LJ, Hollander AP. Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem. J., 1998, 331 Pt 3 727-732

[55] Bae S et al. MYC-dependent oxidative metabolism regulates osteoclastogenesis via nuclear receptor ERRalpha. J. Clin. Invest., 2017, 127: 2555-2568

[56] Barrientos A, Moraes CT. Titrating the effects of mitochondrial complex I impairment in the cell physiology. J. Biol. Chem., 1999, 274: 16188-16197

[57] Ramio-Lluch L et al. Oligomycin A-induced inhibition of mitochondrial ATP-synthase activity suppresses boar sperm motility and in vitro capacitation achievement without modifying overall sperm energy levels. Reprod. Fertil. Dev., 2014, 26: 883-897

[58] Guimaraes EL et al. Mitochondrial uncouplers inhibit hepatic stellate cell activation. BMC Gastroenterol., 2012, 12: 68

[59] Pietrocola F, Galluzzi L, Bravo-San PJ, Madeo F, Kroemer G. Acetyl coenzyme A: a central metabolite and second messenger. Cell Metab, 2015, 21: 805-821

[60] Rahman MM et al. Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages. Blood, 2003, 101: 3451-3459

[61] Hirschey MD, Shimazu T, Huang JY, Schwer B, Verdin E. SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism. Cold Spring Harb Symp. Quant. Biol., 2011, 76: 267-277

[62] Huang JY, Hirschey MD, Shimazu T, Ho L, Verdin E. Mitochondrial sirtuins. Biochim. Biophys. Acta, 2010, 1804: 1645-1651

[63] Shimazu T et al. SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab., 2010, 12: 654-661

[64] Nuutinen H, Lindros K, Hekali P, Salaspuro M. Elevated blood acetate as indicator of fast ethanol elimination in chronic alcoholics. Alcohol, 1985, 2: 623-626

[65] Zakhari S. Overview: how is alcohol metabolized by the body? Alcohol Res. Curr. Rev., 2006, 29: 245-254

[66] Cappariello A, Maurizi A, Veeriah V, Teti A. The great beauty of the osteoclast. Arch. Biochem. Biophys., 2014, 558: 70-78

[67] Park-Min KH. Metabolic reprogramming in osteoclasts. Semin. Immunopathol., 2019, 41: 565-572

[68] Takito, J., Inoue, S. & Nakamura, M. The sealing zone in osteoclasts: a self-organized structure on the bone. Int. J. Mol. Sci. 19, (2018).

[69] Zhang Y et al. PGC1beta organizes the osteoclast cytoskeleton by mitochondrial biogenesis and activation. J. Bone Miner. Res., 2018, 33: 1114-1125

[70] Nakano S et al. G-protein Galpha(13) functions as a cytoskeletal and mitochondrial regulator to restrain osteoclast function. Sci Rep, 2019, 9

[71] Dai J et al. Chronic alcohol ingestion induces osteoclastogenesis and bone loss through IL-6 in mice. J. Clin. Invest., 2000, 106: 887-895

[72] Boraschi-Diaz I et al. Collagen type I degradation fragments act through the collagen receptor LAIR-1 to provide a negative feedback for osteoclast formation. Bone, 2018, 117: 23-30

Funding

National Natural Science Foundation of China (National Science Foundation of China)(31872799)

2020A1515011189 from Guangdong Basic and Applied Basic Research Foundation of China